Kala Pharmaceuticals (KALA) Expected to Beat Earnings Estimates: Should You Buy?

The market expects Kala Pharmaceuticals (KALA) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2020. This widely-known consensus outlook is important in assessing the company’s earnings picture, but a poweThe market expects Kala Pharmaceuticals (KALA) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2020. This widely-known consensus outlook is important in assessing the company’s earnings picture, but a poweRead MoreStocks,InvestingStocks Feed